ProCE Banner Activity

Systematic Review and Meta-Analysis of Outcomes of Soluble Guanylate Cyclase Stimulators in Patients With Heart Failure

Slideset Download
Conference Coverage
In patients with heart failure, sGC stimulators reduced risk of a combined endpoint including cardiovascular death and hospitalization for heart failure in individuals with reduced ejection fraction but had no benefit in those with preserved ejection fraction.

Released: June 28, 2021

Expiration: June 27, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck

Additional Information

Program Medium

This program has been made available online.